Huang FX - Search Results

1

Efficacy and safety of anti-PD-1 inhibitor combined with nab-paclitaxel in Chinese patients with refractory melanoma.

Li JJ, Wang JH, Dingv Y, Li DD, Wen XZ, Zhao JJ, Jiang H, Liu X, Huang FX, Zhang XS. Li JJ, et al. Among authors: huang fx. J Cancer Res Clin Oncol. 2022 May;148(5):1159-1169. doi: 10.1007/s00432-021-03700-9. Epub 2021 Jun 28. J Cancer Res Clin Oncol. 2022. PMID: 34181096

2

Time-varying pattern of recurrence risk for localized melanoma in China.

Wen X, Li D, Zhao J, Li J, Yang T, Ding Y, Peng R, Zhu B, Huang F, Zhang X. Wen X, et al. World J Surg Oncol. 2020 Jan 4;18(1):6. doi: 10.1186/s12957-019-1775-5. World J Surg Oncol. 2020. PMID: 31901239 Free PMC article.

3

SOX2 promotes resistance of melanoma with PD-L1 high expression to T-cell-mediated cytotoxicity that can be reversed by SAHA.

Wu R, Wang C, Li Z, Xiao J, Li C, Wang X, Kong P, Cao J, Huang F, Li Z, Huang Y, Chen Y, Li X, Yang D, Zhang H, Mai J, Feng G, Deng R, Zhu X. Wu R, et al. J Immunother Cancer. 2020 Nov;8(2):e001037. doi: 10.1136/jitc-2020-001037. J Immunother Cancer. 2020. PMID: 33158915 Free PMC article.

4

Adjuvant PD-1 inhibitor versus high-dose interferon α-2b for Chinese patients with cutaneous and acral melanoma: A retrospective cohort analysis.

Li J, Wang J, Li D, Wen X, Ding Y, Liu X, Jiang H, Huang F, Zhang X. Li J, et al. Dermatol Ther. 2021 Sep;34(5):e15067. doi: 10.1111/dth.15067. Epub 2021 Jul 29. Dermatol Ther. 2021. PMID: 34302318

5

Next-generation sequencing in advanced Chinese melanoma reveals therapeutic targets and prognostic biomarkers for immunotherapy.

Huang F, Li J, Wen X, Zhu B, Liu W, Wang J, Jiang H, Ding Y, Li D, Zhang X. Huang F, et al. Sci Rep. 2022 Jun 10;12(1):9559. doi: 10.1038/s41598-022-13391-y. Sci Rep. 2022. PMID: 35688842 Free PMC article.

6

HHLA2 predicts improved prognosis of anti-PD-1/PD-L1 immunotherapy in patients with melanoma.

Huang FX, Wu JW, Cheng XQ, Wang JH, Wen XZ, Li JJ, Zhang Q, Jiang H, Ding QY, Zhu XF, Zhang XS, Ding Y, Li DD. Huang FX, et al. Front Immunol. 2022 Aug 8;13:902167. doi: 10.3389/fimmu.2022.902167. eCollection 2022. Front Immunol. 2022. PMID: 36003385 Free PMC article.

7

Clinical features and response to systemic therapy in NRAS-mutant Chinese melanoma patients.

Wang J, Jiang H, Huang F, Li D, Wen X, Ding Q, Ding Y, Zhang X, Li J. Wang J, et al. J Cancer Res Clin Oncol. 2023 Feb;149(2):701-708. doi: 10.1007/s00432-022-04377-4. Epub 2022 Dec 1. J Cancer Res Clin Oncol. 2023. PMID: 36454283

8

Loss of HRD functional phenotype impedes immunotherapy and can be reversed by HDAC inhibitor in ovarian cancer.

Yang D, Huang FX, Wei W, Li QQ, Wu JW, Huang Y, Li ZL, Zhang HL, Li X, Yuan QE, Chen QS, Feng GK, Rong D, Li JD, Zhu XF. Yang D, et al. Among authors: huang fx. Int J Biol Sci. 2023 Mar 21;19(6):1846-1860. doi: 10.7150/ijbs.79654. eCollection 2023. Int J Biol Sci. 2023. PMID: 37063431 Free PMC article.

9

Efficacy and safety of immune checkpoint inhibitors with or without radiotherapy in metastatic non-small cell lung cancer: A systematic review and meta-analysis.

Liu Z, Xu T, Chang P, Fu W, Wei J, Xia C, Wang Q, Li M, Pu X, Huang F, Ge C, Gao Y, Gong S, Liu C, Dong L. Liu Z, et al. Front Pharmacol. 2023 Jan 24;14:1064227. doi: 10.3389/fphar.2023.1064227. eCollection 2023. Front Pharmacol. 2023. PMID: 36762107 Free PMC article.

10

Identification of three small nucleolar RNAs (snoRNAs) as potential prognostic markers in diffuse large B-cell lymphoma.

Li MW, Huang FX, Xie ZC, Hong HY, Xu QY, Peng ZG. Li MW, et al. Among authors: huang fx. Cancer Med. 2023 Feb;12(3):3812-3829. doi: 10.1002/cam4.5115. Epub 2022 Aug 16. Cancer Med. 2023. PMID: 36812125 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

44 results

Search Page

Filters